[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
November 1996

Host Defense Mechanisms of Surgical PatientsFriend or Foe?

Author Affiliations

From the Departments of Surgery and Microbiology and Immunology, McGill University, Montreal, Quebec.

Arch Surg. 1996;131(11):1136-1140. doi:10.1001/archsurg.1996.01430230018004
Abstract

Surgeons and members of this society commonly deal with 2 types of infections of great concern in hospitalized patients. These are hospital-acquired pneumonia and intra-abdominal infections. Both of these infections have the potential for severe morbidity and mortality. We have learned how to classify the types of intra-abdominal infections into primary peritonitis, localized abscess with or without peritonitis, diffuse suppurative peritonitis, or combinations of these classifications. Each of these conditions carries a different mortality risk proportional to its severity. We have also learned how to diagnose surgical infections by properly taking medical history and performing physical examination, appropriate laboratory testing, and sophisticated imaging techniques. The treatment of intra-abdominal infections has become fairly standardized and includes surgical or percutaneous drainage of the infected material, correction of the underlying pathologic symptoms, and broad-spectrum empirical antibiotic therapy.

References
1.
Solomkin JS, Reinhart HH, Dellinger EP, et al.  Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections . Ann Surg . 1996; 223:303-315.Article
2.
Christou NV, Turgeon P, Wassef R, et al.  Management of intra-abdominal infections: the case for intra-operative cultures and comprehensive broad spectrum antibiotic coverage . Arch Surg . 1996;131:1193-1201.Article
3.
Marshall J, Sweeney D.  Microbial infection and the septic response in critical surgical illness: sepsis, not infection, determines critical outcome . Arch Surg . 1990;125:17-21.Article
4.
Meksem K, Leister D, Peleman J, Zabeau M, Salamini F, Gebhardt C.  A high-resolution map of the vicinity of the R1 locus on chromosome V of potato based on RFLP and AFLP markers . Mol Gen Genet . 1995;249:74-81.Article
5.
Kema GHJ, Annone JG, Sayoud R, Vansilfhout CH, Vanginkel M, Debree J.  Genetic variation for virulence and resistance in the wheat—Mycosphaerella graminicola pathosystem, 1: interactions between pathogen isolates and host cultivars . Phytopathology . 1996;86:200-212.Article
6.
Kreps JA, Ponappa T, Dong WQ.  Molecular basis of α-methyltryptophan resistance in Amt-1, a mutant of arabidopsis thaliana with altered tryptophan metabolism . Plant Physiol . 1996;110:1159-1165.Article
7.
Liu J, Fujiwara TM, Buu NT, et al.  Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance—associated macrophage protein gene . Am J Hum Genet . 1995;56:845-853.
8.
Malo D, Vogan K, Vidal S, et al.  Haplotype mapping and sequence analysis of the mouse Nramp gene predicts susceptibility to infection with intracellular parasites . Genomics . 1994;23:51-61.Article
9.
Goldmann W, Hunter N, Smith G, Foster J, Hope J.  Prp genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie . J Gen Virol . 1994;75( (pt 5) ):989-995.Article
10.
Just JJ, Abrams E, Louie LG, et al.  Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1 . J Pediatr . 1995;127:544-549.Article
11.
Huck S, Zouali M.  The human B-cell repertoire: expression in normal and pathological conditions . Med Sci . 1995;11:1566-1575.
12.
Epplen C, Buitkamp J, Rumpf H, Dsouza M, Epplen JT.  Immunoprinting reveals different genetic bases for (auto)immune diseases . Electrophoresis . 1995; 16:1693-1697.Article
13.
Cabrera M, Shaw MA, Sharples C, et al.  Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis . J Exp Med . 1995; 182:1259-1264.Article
14.
Stuber F, Petersen M, Bokelmann F, Schade U.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis . Crit Care Med . 1996;24:381-384.Article
×